Harbor Capital Advisors Inc. Raises Position in Cellebrite DI Ltd. (NASDAQ:CLBT)

Harbor Capital Advisors Inc. lifted its stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) by 65.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 157,671 shares of the company’s stock after buying an additional 62,320 shares during the period. Harbor Capital Advisors Inc. owned about 0.08% of Cellebrite DI worth $3,473,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Quarry LP purchased a new position in Cellebrite DI during the 3rd quarter worth $27,000. Point72 Asia Singapore Pte. Ltd. boosted its holdings in Cellebrite DI by 59.6% during the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 2,724 shares of the company’s stock worth $33,000 after purchasing an additional 1,017 shares during the last quarter. Advisors Asset Management Inc. grew its position in Cellebrite DI by 130.5% in the 3rd quarter. Advisors Asset Management Inc. now owns 3,077 shares of the company’s stock worth $52,000 after purchasing an additional 1,742 shares in the last quarter. Pathway Financial Advisers LLC increased its stake in Cellebrite DI by 1,583.8% in the 3rd quarter. Pathway Financial Advisers LLC now owns 4,378 shares of the company’s stock valued at $74,000 after buying an additional 4,118 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado bought a new position in shares of Cellebrite DI during the 2nd quarter worth approximately $71,000. Institutional investors own 45.88% of the company’s stock.

Cellebrite DI Stock Down 1.2 %

NASDAQ CLBT opened at $21.57 on Friday. The company has a market cap of $4.44 billion, a PE ratio of -13.92, a price-to-earnings-growth ratio of 2.71 and a beta of 1.46. The firm’s 50-day simple moving average is $20.39 and its two-hundred day simple moving average is $17.19. Cellebrite DI Ltd. has a 52 week low of $7.91 and a 52 week high of $22.91.

Cellebrite DI (NASDAQ:CLBT) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.09 by $0.05. Cellebrite DI had a negative net margin of 82.28% and a positive return on equity of 122.59%. The company had revenue of $106.90 million during the quarter, compared to the consensus estimate of $102.06 million. During the same period last year, the firm earned $0.09 EPS. Cellebrite DI’s revenue for the quarter was up 27.0% on a year-over-year basis. As a group, equities research analysts anticipate that Cellebrite DI Ltd. will post 0.32 EPS for the current year.

Analyst Ratings Changes

CLBT has been the subject of several recent analyst reports. TD Cowen upped their target price on Cellebrite DI from $20.00 to $23.00 and gave the company a “buy” rating in a report on Monday, September 23rd. JPMorgan Chase & Co. raised their target price on Cellebrite DI from $22.00 to $24.00 and gave the company an “overweight” rating in a research report on Monday, December 16th. Needham & Company LLC boosted their price target on shares of Cellebrite DI from $17.00 to $21.00 and gave the stock a “buy” rating in a report on Thursday, November 7th. Finally, Craig Hallum increased their price target on shares of Cellebrite DI from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Eight analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $20.57.

Cellebrite DI Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.